Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaginal Antifungal Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Fluconazole
1.2.3 Clotrimazole
1.2.4 Ketoconazole
1.2.5 Others
1.3 Market by Application
1.3.1 Global Vaginal Antifungal Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaginal Antifungal Market Perspective (2018-2033)
2.2 Vaginal Antifungal Growth Trends by Region
2.2.1 Global Vaginal Antifungal Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Vaginal Antifungal Historic Market Size by Region (2018-2023)
2.2.3 Vaginal Antifungal Forecasted Market Size by Region (2024-2033)
2.3 Vaginal Antifungal Market Dynamics
2.3.1 Vaginal Antifungal Industry Trends
2.3.2 Vaginal Antifungal Market Drivers
2.3.3 Vaginal Antifungal Market Challenges
2.3.4 Vaginal Antifungal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaginal Antifungal Players by Revenue
3.1.1 Global Top Vaginal Antifungal Players by Revenue (2018-2023)
3.1.2 Global Vaginal Antifungal Revenue Market Share by Players (2018-2023)
3.2 Global Vaginal Antifungal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaginal Antifungal Revenue
3.4 Global Vaginal Antifungal Market Concentration Ratio
3.4.1 Global Vaginal Antifungal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaginal Antifungal Revenue in 2022
3.5 Vaginal Antifungal Key Players Head office and Area Served
3.6 Key Players Vaginal Antifungal Product Solution and Service
3.7 Date of Enter into Vaginal Antifungal Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaginal Antifungal Breakdown Data by Type
4.1 Global Vaginal Antifungal Historic Market Size by Type (2018-2023)
4.2 Global Vaginal Antifungal Forecasted Market Size by Type (2024-2033)
5 Vaginal Antifungal Breakdown Data by Application
5.1 Global Vaginal Antifungal Historic Market Size by Application (2018-2023)
5.2 Global Vaginal Antifungal Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Vaginal Antifungal Market Size (2018-2033)
6.2 North America Vaginal Antifungal Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Vaginal Antifungal Market Size by Country (2018-2023)
6.4 North America Vaginal Antifungal Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaginal Antifungal Market Size (2018-2033)
7.2 Europe Vaginal Antifungal Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Vaginal Antifungal Market Size by Country (2018-2023)
7.4 Europe Vaginal Antifungal Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaginal Antifungal Market Size (2018-2033)
8.2 Asia-Pacific Vaginal Antifungal Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Vaginal Antifungal Market Size by Region (2018-2023)
8.4 Asia-Pacific Vaginal Antifungal Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaginal Antifungal Market Size (2018-2033)
9.2 Latin America Vaginal Antifungal Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Vaginal Antifungal Market Size by Country (2018-2023)
9.4 Latin America Vaginal Antifungal Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaginal Antifungal Market Size (2018-2033)
10.2 Middle East & Africa Vaginal Antifungal Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Vaginal Antifungal Market Size by Country (2018-2023)
10.4 Middle East & Africa Vaginal Antifungal Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ANI Pharmaceuticals
11.1.1 ANI Pharmaceuticals Company Detail
11.1.2 ANI Pharmaceuticals Business Overview
11.1.3 ANI Pharmaceuticals Vaginal Antifungal Introduction
11.1.4 ANI Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023)
11.1.5 ANI Pharmaceuticals Recent Development
11.2 Lupin
11.2.1 Lupin Company Detail
11.2.2 Lupin Business Overview
11.2.3 Lupin Vaginal Antifungal Introduction
11.2.4 Lupin Revenue in Vaginal Antifungal Business (2018-2023)
11.2.5 Lupin Recent Development
11.3 Unique Pharmaceuticals
11.3.1 Unique Pharmaceuticals Company Detail
11.3.2 Unique Pharmaceuticals Business Overview
11.3.3 Unique Pharmaceuticals Vaginal Antifungal Introduction
11.3.4 Unique Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023)
11.3.5 Unique Pharmaceuticals Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Vaginal Antifungal Introduction
11.4.4 Pfizer Revenue in Vaginal Antifungal Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 SCYNEXIS
11.5.1 SCYNEXIS Company Detail
11.5.2 SCYNEXIS Business Overview
11.5.3 SCYNEXIS Vaginal Antifungal Introduction
11.5.4 SCYNEXIS Revenue in Vaginal Antifungal Business (2018-2023)
11.5.5 SCYNEXIS Recent Development
11.6 Bausch Health Companies
11.6.1 Bausch Health Companies Company Detail
11.6.2 Bausch Health Companies Business Overview
11.6.3 Bausch Health Companies Vaginal Antifungal Introduction
11.6.4 Bausch Health Companies Revenue in Vaginal Antifungal Business (2018-2023)
11.6.5 Bausch Health Companies Recent Development
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Company Detail
11.7.2 Hikma Pharmaceuticals Business Overview
11.7.3 Hikma Pharmaceuticals Vaginal Antifungal Introduction
11.7.4 Hikma Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023)
11.7.5 Hikma Pharmaceuticals Recent Development
11.8 Pacgen Life Science Corporation
11.8.1 Pacgen Life Science Corporation Company Detail
11.8.2 Pacgen Life Science Corporation Business Overview
11.8.3 Pacgen Life Science Corporation Vaginal Antifungal Introduction
11.8.4 Pacgen Life Science Corporation Revenue in Vaginal Antifungal Business (2018-2023)
11.8.5 Pacgen Life Science Corporation Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Detail
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Vaginal Antifungal Introduction
11.9.4 Astellas Pharma Revenue in Vaginal Antifungal Business (2018-2023)
11.9.5 Astellas Pharma Recent Development
11.10 Mycovia Pharmaceuticals
11.10.1 Mycovia Pharmaceuticals Company Detail
11.10.2 Mycovia Pharmaceuticals Business Overview
11.10.3 Mycovia Pharmaceuticals Vaginal Antifungal Introduction
11.10.4 Mycovia Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023)
11.10.5 Mycovia Pharmaceuticals Recent Development
11.11 PEPTONIC Medical
11.11.1 PEPTONIC Medical Company Detail
11.11.2 PEPTONIC Medical Business Overview
11.11.3 PEPTONIC Medical Vaginal Antifungal Introduction
11.11.4 PEPTONIC Medical Revenue in Vaginal Antifungal Business (2018-2023)
11.11.5 PEPTONIC Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Vaginal Antifungal Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Fluconazole
Table 3. Key Players of Clotrimazole
Table 4. Key Players of Ketoconazole
Table 5. Key Players of Others
Table 6. Global Vaginal Antifungal Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Vaginal Antifungal Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Vaginal Antifungal Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Vaginal Antifungal Market Share by Region (2018-2023)
Table 10. Global Vaginal Antifungal Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Vaginal Antifungal Market Share by Region (2024-2033)
Table 12. Vaginal Antifungal Market Trends
Table 13. Vaginal Antifungal Market Drivers
Table 14. Vaginal Antifungal Market Challenges
Table 15. Vaginal Antifungal Market Restraints
Table 16. Global Vaginal Antifungal Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Vaginal Antifungal Market Share by Players (2018-2023)
Table 18. Global Top Vaginal Antifungal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Antifungal as of 2022)
Table 19. Ranking of Global Top Vaginal Antifungal Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Vaginal Antifungal Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Vaginal Antifungal Product Solution and Service
Table 23. Date of Enter into Vaginal Antifungal Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vaginal Antifungal Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Vaginal Antifungal Revenue Market Share by Type (2018-2023)
Table 27. Global Vaginal Antifungal Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Vaginal Antifungal Revenue Market Share by Type (2024-2033)
Table 29. Global Vaginal Antifungal Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Vaginal Antifungal Revenue Market Share by Application (2018-2023)
Table 31. Global Vaginal Antifungal Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Vaginal Antifungal Revenue Market Share by Application (2024-2033)
Table 33. North America Vaginal Antifungal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Vaginal Antifungal Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Vaginal Antifungal Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Vaginal Antifungal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Vaginal Antifungal Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Vaginal Antifungal Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Vaginal Antifungal Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Vaginal Antifungal Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Vaginal Antifungal Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Vaginal Antifungal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Vaginal Antifungal Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Vaginal Antifungal Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Vaginal Antifungal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Vaginal Antifungal Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Vaginal Antifungal Market Size by Country (2024-2033) & (US$ Million)
Table 48. ANI Pharmaceuticals Company Detail
Table 49. ANI Pharmaceuticals Business Overview
Table 50. ANI Pharmaceuticals Vaginal Antifungal Product
Table 51. ANI Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 52. ANI Pharmaceuticals Recent Development
Table 53. Lupin Company Detail
Table 54. Lupin Business Overview
Table 55. Lupin Vaginal Antifungal Product
Table 56. Lupin Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 57. Lupin Recent Development
Table 58. Unique Pharmaceuticals Company Detail
Table 59. Unique Pharmaceuticals Business Overview
Table 60. Unique Pharmaceuticals Vaginal Antifungal Product
Table 61. Unique Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 62. Unique Pharmaceuticals Recent Development
Table 63. Pfizer Company Detail
Table 64. Pfizer Business Overview
Table 65. Pfizer Vaginal Antifungal Product
Table 66. Pfizer Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. SCYNEXIS Company Detail
Table 69. SCYNEXIS Business Overview
Table 70. SCYNEXIS Vaginal Antifungal Product
Table 71. SCYNEXIS Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 72. SCYNEXIS Recent Development
Table 73. Bausch Health Companies Company Detail
Table 74. Bausch Health Companies Business Overview
Table 75. Bausch Health Companies Vaginal Antifungal Product
Table 76. Bausch Health Companies Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 77. Bausch Health Companies Recent Development
Table 78. Hikma Pharmaceuticals Company Detail
Table 79. Hikma Pharmaceuticals Business Overview
Table 80. Hikma Pharmaceuticals Vaginal Antifungal Product
Table 81. Hikma Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 82. Hikma Pharmaceuticals Recent Development
Table 83. Pacgen Life Science Corporation Company Detail
Table 84. Pacgen Life Science Corporation Business Overview
Table 85. Pacgen Life Science Corporation Vaginal Antifungal Product
Table 86. Pacgen Life Science Corporation Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 87. Pacgen Life Science Corporation Recent Development
Table 88. Astellas Pharma Company Detail
Table 89. Astellas Pharma Business Overview
Table 90. Astellas Pharma Vaginal Antifungal Product
Table 91. Astellas Pharma Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 92. Astellas Pharma Recent Development
Table 93. Mycovia Pharmaceuticals Company Detail
Table 94. Mycovia Pharmaceuticals Business Overview
Table 95. Mycovia Pharmaceuticals Vaginal Antifungal Product
Table 96. Mycovia Pharmaceuticals Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 97. Mycovia Pharmaceuticals Recent Development
Table 98. PEPTONIC Medical Company Detail
Table 99. PEPTONIC Medical Business Overview
Table 100. PEPTONIC Medical Vaginal Antifungal Product
Table 101. PEPTONIC Medical Revenue in Vaginal Antifungal Business (2018-2023) & (US$ Million)
Table 102. PEPTONIC Medical Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaginal Antifungal Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Vaginal Antifungal Market Share by Type: 2022 VS 2033
Figure 3. Fluconazole Features
Figure 4. Clotrimazole Features
Figure 5. Ketoconazole Features
Figure 6. Others Features
Figure 7. Global Vaginal Antifungal Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Vaginal Antifungal Market Share by Application: 2022 VS 2033
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Pharmacy Case Studies
Figure 12. Vaginal Antifungal Report Years Considered
Figure 13. Global Vaginal Antifungal Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Vaginal Antifungal Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Vaginal Antifungal Market Share by Region: 2022 VS 2033
Figure 16. Global Vaginal Antifungal Market Share by Players in 2022
Figure 17. Global Top Vaginal Antifungal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Antifungal as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Vaginal Antifungal Revenue in 2022
Figure 19. North America Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Vaginal Antifungal Market Share by Country (2018-2033)
Figure 21. United States Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Vaginal Antifungal Market Share by Country (2018-2033)
Figure 25. Germany Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Vaginal Antifungal Market Share by Region (2018-2033)
Figure 33. China Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Vaginal Antifungal Market Share by Country (2018-2033)
Figure 41. Mexico Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Vaginal Antifungal Market Share by Country (2018-2033)
Figure 45. Turkey Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Vaginal Antifungal Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. ANI Pharmaceuticals Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 48. Lupin Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 49. Unique Pharmaceuticals Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 51. SCYNEXIS Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 52. Bausch Health Companies Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 53. Hikma Pharmaceuticals Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 54. Pacgen Life Science Corporation Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 55. Astellas Pharma Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 56. Mycovia Pharmaceuticals Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 57. PEPTONIC Medical Revenue Growth Rate in Vaginal Antifungal Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed